top of page
Executive Spotlights

Alamar Biosciences Raises $128M in Oversubscribed Series C

Fremont, CA, February 26, 2024 (PRNewswire)  -- Alamar Biosciences, a company specializing in precision proteomics for early disease detection, announced the close of $100 million in Series C financing today, with an additional $28 million expected to be closed within the next 30 days. This additional capital increases Alamar's total funding to nearly $250 million.

Read full article here.

Recent Posts

See All

Radiant Vision Systems Appoints new CEO

Redmond, WA, July 1, 2024 (Radiant) -- Radiant Vision Systems has appointed Stone Jiang as their new CEO, succeeding Doug Kreysar who is retiring. Jiang, previously the Executive Vice President and

Orion and Merck Secure $1.63B Agreement

Rahway, NJ, July 1, 2024 (Business Wire) -- Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, and Orion Corporation ("Orion") have agreed to convert their co-development and co-commercial


Life Science Headlines
bottom of page